Please assess the completion status of the following clinical trial:

Trial Title: Islet Allotransplantation With Steroid Free Immunosuppression

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* type 1 diabetes documented for more than 5 years~* arginine stimulated C-peptide lower than 0.2 ng/mL~* one of the following:hypoglycemia unawareness OR metabolic lability documented by one or more severe hypoglycemias or two or more hospital admissions for ketoacidosis within the previous year.~Exclusion Criteria:~* body mass index greater than 28 kg/m2~* non stable arteriopathy or heart disease~* active infection~* previous transplantation~* hyperimmunization~* insulin daily needs above 1.2 U/Kg~* creatinine clearance below 60 ml/mn or urinary albumin excretion above 300 mg/d~* malignancy~* smoking~* desire for pregnancy~* psychiatric disorders~* lack of compliance

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- islet transplantation (Type: EXPERIMENTAL): Each participant received up to three sequential fresh islet infusions within three months.

Based on this trial design, predict the completion outcome and termination type (if applicable).